Webinar 08: “CAR-T Cell Therapy: Precision Immunoengineering in Modern Oncology”

Webinar 08: “CAR-T Cell Therapy: Precision Immunoengineering in Modern Oncology”

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

You are kindly invited to the 8th IMMUNO-model webinar entitled “CAR-T Cell Therapy: Precision Immunoengineering in Modern Oncology” that will be streamed live on the ZOOM platform on June 10, 2025, at 2.00 – 4.00 pm CET.

The webinar will consist of two presentations and a question-and-answer session:

  • Ciprian Tomuleasa, Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Romania
    Designing anti-ROR1 CAR-T cells for mantle cell lymphoma
  • Jordi Minguillón, Advanced Therapy Unit (CIEMAT-IIS-FJD) & Pediatric Oncohematology Unit (IdiPAZ CNIO), Spain
    Clinical and translational research on CAR-T cell therapy for pediatric cancer

The webinar will be moderated by René Winkler, Josep Carreras Leukaemia Research Institute, Spain.

Description of speakers and presentations here.

For further information, please contact the IMMUNO-model Science Communication Coordinator Dr. Barbara Breznik (barbara.breznik@nib.si).

Check out Webinar here.

Latest Updates

Conference title: ESMO Immuno-Oncology Congress 2025Conference web-page: https://www.esmo.org/meeting-calendar/esmo-immuno-oncology-congress-2025 Conference venue: Queen Elizabeth II Centre in London, United Kingdom. Conference start and end date: 10/12/2025 to 12/12/2025 Title of the presentation:...
Training in techniques for generating patient-derived immuno-oncology models from squamous cell carcinomas I am Norbert Nass, investigator at Brandenburg Medical School (MHB), Institute of Pathology in Brandenburg / Havel, Germany....
Attending the 3R Länd Conference in Tübingen, Germany, with the support of the YRI IMMUNO-model grant was a valuable opportunity to learn about cutting-edge alternatives to animal testing and their...
In the scope of 1 month long STSM at the Science for life laboratory in Stockholm, Sweden, we combined advanced 3D glioblastoma models and different regions of glioblastoma tissue with...
Title: Engineered immune-competent models of metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma using patient-derived hepatocyte organoids and biomaterials Start and end date: 16/02/2026 to 17/04/2026 I am Ana Margarida...
STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter